HUMIRA (ADALIMUMAB) ANTITRUST LITIGATION, CASE NO. 19-CV-01873 (N.D. ILL.)

LGN represents end payor plaintiffs who allege that drug companies entered into an anticompetitive scheme to restrain competition in the market for Humira and its biosimilar competitors.  This action is pending in the United States District Court of the Northern District of Illinois before the Honorable Manish S. Shah.